Cytokine dysregulation

Cytokine dysregulation refers to the abnormal secretion of cytokines, leading to systemic inflammation. According to WHO and CDC clinical guidelines, this condition can be triggered by severe infections or environmental stressors. In enterprise risk management, it falls under the Health Hazard Risk category, requiring assessment under ISO 45001:2018 Clause 6.1.2 (Hazard Identification and Risk Assessment) to ensure employee safety and operational resilience.

Implementation follows three steps: 1. Identify occupational scenarios (e.g., chemical exposure, high-stress environments) that trigger immune dysregulation. 2. Quantify risks using ISO 45001 risk-adjusted-by-severity methodology. 3. Establish monitoring and BCP protocols. For instance, a Taiwan-based electronics manufacturer implemented health monitoring after identifying staff with high-stress-related inflammatory markers, reducing absenteeism by 15% and achieving zero non-conformities in ISO 45001 audits.

Three main challenges exist: 1. Data Privacy: Collecting employee health data requires strict compliance with the Taiwan Personal Data Protection Act (PDPA) and GDPR. 2. Technical Expertise: Measuring cytokine markers requires specialized laboratory partnerships. 3. Cost-Benefit Justification: Management often views health monitoring as a cost center rather than a value-add. Solutions include partnering with certified occupational health clinics, using anonymized data-driven analytics, and integrating health KPIs into the overall Risk Management Framework (RTO/RPO targets).

Winners Consulting Services Co., Ltd. specializes in Cytokine dysregulation for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact